“It’s time we reevaluate the standards for approving these mergers. It’s time we pass legislation to lower drug prices. And it’s time we rethink the structure of leadership at big pharmaceutical companies.”
0
Like
Save
- Tags:
capitalism, healthcare, profiteering, us
- Categories: Economy
){kind=link}